Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2933964 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL6350234 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1537141 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL10878040 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL5859492 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1685498 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4804737 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL6350372 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8162957 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1784336 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4511369-A | DUEL BASICITY FLUX | INSTITUT FRANCAIS DU PETROLE (FR) | 1985-04-16 | — | — | US | claimed |
| US-12606512-B2 | Process for the hydroformylation of olefins in homogeneous phase | OXEA GMBH (DE) | 2026-04-21 | — | — | US | disclosed |
| US-12503418-B2 | Process for the preparation of polycyclic aliphatic dialdehydes | OXEA GMBH (DE) | 2025-12-23 | — | — | US | disclosed |
| US-20250228777-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ARES CAPITAL CORPORATION, AS AGENT | 2025-07-17 | — | — | US | disclosed |
| US-12275883-B2 | Multifunctional additive compounds | HUNTSMAN PETROCHEMICAL LLC | 2025-04-15 | — | — | US | disclosed |
| US-12263248-B2 | Compounds and compositions for intracellular delivery of therapeutic agents | MODERNATX, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| EP-4196281-B1 | METHOD FOR FLOTATION OF A SILICATE-CONTAINING IRON ORE | BASF SE (DE) | 2024-10-09 | — | — | EP | disclosed |
| EP-3927795-B1 | MULTIFUNCTIONAL ADDITIVE COMPOUNDS | HUNTSMAN PETROCHEMICAL LLC (US) | 2024-05-22 | — | — | EP | disclosed |
| US-20240043362-A1 | PROCESS FOR THE PREPARATION OF POLYCYCLIC ALIPHATIC DIALDEHYDES | OXEA GMBH (DE) | 2024-02-08 | — | — | US | disclosed |
| US-20230399283-A1 | PROCESS FOR THE HYDROFORMYLATION OF OLEFINS IN HOMOGENEOUS PHASE | OXEA GMBH (DE) | 2023-12-14 | — | — | US | disclosed |
| EP-0924182-A1 | Process for the preparation of aldehydes | Celanese GmbH (DE) | 1999-06-23 | — | — | EP | disclosed |
| US-5472624-A | Wear resistance, extreme pressure lubricant | INSTITUT FRANCAIS DU PETROLE (FR) | 1995-12-05 | — | — | US | disclosed |
| US-5449386-A | Fuel additives, antisedimentation agents | INSTITUT FRANCAIS DU PETROLE (FR) | 1995-09-12 | — | — | US | disclosed |
| US-5433755-A | Additive formulation for fuels incorporating ester function products and a detergent-dispersant | INSTITUT FRANCAIS DU PETROLE (FR) | 1995-07-18 | — | — | US | disclosed |
| US-5106515-A | POLYMERS DERIVED FROM UNSATURATED POLYESTERS BY ADDITION OF COMPOUNDS WITH AN AMINE FUNCTION AND THEIR USE AS ADDITIVES MODIFYING THE PROPERTIES OF PETROLEUM MIDDLE DISTILLATES WHEN COLD | INSTITUT FRANCAIS DU PETROLE (FR) | 1992-04-21 | — | — | US | disclosed |
| US-5001202-A | Polymers derived from unsaturated polyesters by addition of compounds with an amine function and their use as additives modifying the properties of petroleum middle distillates when cold | INSTITUT FRANCAIS DU PETROLE (FR) | 1991-03-19 | — | — | US | disclosed |
| US-4511369-A | DUEL BASICITY FLUX | INSTITUT FRANCAIS DU PETROLE (FR) | 1985-04-16 | — | — | US | disclosed |
| US-4260750-A | OF DIENES, TRIARYLPHOSPHINE CATALYST | RHONE-POULENC INDUSTRIES (FR) | 1981-04-07 | — | — | US | disclosed |
| US-3999942-A | N-Acyloyl-N-alkyl-alkylenediamines as dye levelers | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
| US-3941907-A | ORGANIC SULFATE OR SULFONATE SALT OF ALKYLENEDIAMINE | HENKEL & CIE G.M.B.H. (DT) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12263248-B2 | Compounds and compositions for intracellular delivery of therapeutic agents | LNPK, PLTP, PLIN3 | DNM1 908/4885TSHR 3089/4885MEN1 3647/4885 |
| US-12275883-B2 | Multifunctional additive compounds | MAOA, MAOB, AS3MT | DNM1 2087/4885TSHR 4806/4885MEN1 605/4885 |
| US-20240043362-A1 | PROCESS FOR THE PREPARATION OF POLYCYCLIC ALIPHATIC DIALDEHYDES | DDT, SHARPIN, DBF4 | DNM1 4238/4885TSHR 4007/4885MEN1 314/4885 |
| US-20230399283-A1 | PROCESS FOR THE HYDROFORMYLATION OF OLEFINS IN HOMOGENEOUS PHASE | HMOX1, HAO2, HAAO | DNM1 3610/4885TSHR 4620/4885MEN1 3887/4885 |
| US-12503418-B2 | Process for the preparation of polycyclic aliphatic dialdehydes | DDT, SHARPIN, DBF4 | DNM1 4238/4885TSHR 4007/4885MEN1 314/4885 |
| US-12606512-B2 | Process for the hydroformylation of olefins in homogeneous phase | HMOX1, HAO2, AQP1 | DNM1 3366/4885TSHR 3976/4885MEN1 3135/4885 |
| US-20250228777-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | LNPK, PLTP, PLIN3 | DNM1 908/4885TSHR 3089/4885MEN1 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.